Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer - Wikidata - wikimedia - TriplyDB

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer

http://www.wikidata.org/entity/Q33392476

about

Gallbladder Cancer in the 21st Century.Targeted Therapy in Biliary Tract Cancers In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.Iron chelators in photodynamic therapy revisited: synergistic effect by novel highly active thiosemicarbazones.Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships.Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.

P2860

Q26784174-FB258315-3765-44F0-85E6-64DF61098913 Q26798443-3BF9A1DB-E305-4AE9-85BB-FBA1D8A1FB3D Q28550205-5B25FA77-135E-4E7D-B8E9-FC44A0EDC653 Q33402598-92E62F06-69A8-40F0-8229-7BF221C92A50 Q33636546-3696D988-C2DC-418D-930B-0BFD6C983F93 Q35348485-8C3947E1-282F-4748-8B7A-EC89782E2316 Q37708984-2F4A8C6E-799A-4091-83FC-793376592144

P2860

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer

http://www.wikidata.org/entity/Q33392476

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@ast

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@en

type

label

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@ast

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@en

prefLabel

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@ast

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@en

P1433

Q33392476-40495C3D-BA54-436C-A605-01F80E441281

P1476

Q33392476-B8187BA6-CFB8-4A7D-8A0A-EAE43C4F919A

P2093

Q33392476-08291B37-8AB7-4D79-A196-8B94DAF98984

Q33392476-191C0DA9-955D-4898-8971-0C142304BFD7

Q33392476-204A5586-7F2B-4A97-B94D-BA751A22B1E2

Q33392476-25947D84-888C-4382-B4DE-F94CA7002C71

Q33392476-40604995-01B4-4D26-8AF0-06CBB79B914A

Q33392476-447E5AEE-C92F-4BF2-93F7-E3DC98B88E90

Q33392476-6EA618BD-8F46-4E8A-848C-7DAEC389BF9C

Q33392476-87B28540-EDEC-4ADD-B189-D68EC511E954

Q33392476-BE7B6E7D-F8B0-4675-A29E-2859716FBFE1

Q33392476-E5BD54D4-906C-4095-BE63-F4076B078F59

P2860

Q33392476-05DBEA8A-488F-4F07-BCAF-A90C95C1B157

Q33392476-0D538786-6342-4E09-BF89-BC838B6D9488

Q33392476-11929B48-9A44-4AE0-973C-E31DBA8A9783

Q33392476-15DE87D3-5846-4EFB-AAFA-424DD48D505F

Q33392476-1B1BB4F7-9219-4688-A2FD-CA7044645279

Q33392476-1C90808E-B602-4FE6-8F75-B5D0286F6096

Q33392476-285C043E-B3D9-4A56-A2A9-70FEFDC64296

Q33392476-297ABD27-B54E-412A-9917-82AD82B1AEEF

Q33392476-2D518F53-1EA1-422E-88B9-D5AA4CEAE08A

Q33392476-2FAC4AAC-8E61-45A6-B237-083AA0E71890

P2888

Q33392476-83535FD0-5AF4-432C-9450-616DCFE8E6E5

P304

Q33392476-17EBB63A-B86D-4C04-AE5D-4352BE13A938

P31

Q33392476-885AAAAE-2201-42E3-B4C0-ACFF0B299E17

P356

Q33392476-CA40FD30-9462-4B8F-9DA2-C775CF6F3EEC

P433

Q33392476-2E1676D4-AD35-4BFA-8CC8-0604A2CBDC1A

P478

Q33392476-CF60B837-31C4-4671-A0F0-CA919770A2FB

P577

Q33392476-B063E60C-B97A-453E-9C4C-84C64609D4CF

P5875

Q33392476-C36736F2-7D93-4642-B4DE-05D0D39BA9BB

P6179

Q33392476-2FDBBF61-64BA-43A3-A5FC-259920CD1A43

P698

Q33392476-35BDC237-0F4C-4D6D-8824-DC880DABA49A

P921

Q33392476-FA942E03-78AE-499B-A5B4-A3807F0AEAB2

P932

Q33392476-47ED4526-9A71-46AF-9DD7-87FB81746214

P356

S00280-010-1481-Z

P1433

Cancer Chemotherapy and Pharmacology

P1476

Phase II trial of the ribonucl ...... advanced biliary tract cancer

@en

P2093

Abby Siegel

http://www.w3.org/2001/XMLSchema#string

Allyson J Ocean

http://www.w3.org/2001/XMLSchema#string

Andreas Kaubish

http://www.w3.org/2001/XMLSchema#string

Dan Matulich

http://www.w3.org/2001/XMLSchema#string

Igor Espinoza-Delgado

http://www.w3.org/2001/XMLSchema#string

Joseph A Sparano

http://www.w3.org/2001/XMLSchema#string

Maureen E Lane

http://www.w3.org/2001/XMLSchema#string

Maureen M Ward

http://www.w3.org/2001/XMLSchema#string

Max Sung

http://www.w3.org/2001/XMLSchema#string

Nancy Hamel

http://www.w3.org/2001/XMLSchema#string

P2860

Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint

Cancer statistics, 2009

A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.

Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study.

A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium.

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.

Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer.

P2888

s00280-010-1481-z

P304

379-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-010-1481-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47567485

http://www.w3.org/2001/XMLSchema#string

P6179

1030881733

http://www.w3.org/2001/XMLSchema#string

P698

20981545

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

3446256

http://www.w3.org/2001/XMLSchema#string